* During the scientific sessions, all participants can look around and visit the TWC 2019 exhibition booths.
| Registration | |||
| Opening Ceremony (08:30-09:30) Gi Jeong Cheon |
Opening, KAST International Symposium / Congratulatory Remarks | Myung Chul Lee | KAST |
| Appreciation Plaque for Past Organizers | Dong Soo Lee/Jae Min Jeong | Co-Chairpersons | |
| Opening Remarks | Dong Soo Lee/Jae Min Jeong | Co-Chairpersons | |
| Coffee Break (09:30-10:00) and Exhibition | |||
| Keynote 1 (10:00-10:30) |
Uncovering Novel Biomarkers for Next Generation Theranostics | Sunghoon Kim | Korea |
| Chair: Dong Soo Lee | |||
| Scientific Session 1 (10:30-12:00) |
Current Status of Theranostics | ||
| Chairs: | Clinical Trials Supporting FDA/EMA Approval of Lutathera | Tessa Brabander | The Netherlands |
| Kyung Han Lee | Clinical Experiences with PSMA-1007: Current Status | Kambiz Rahbar | Germany |
| Horacio Amaral | Clinical Experiences of 177Lu PSMA Combined or for Other Cancers | Markus Essler | Germany |
| Future of Theranostics in Germany | Wolfgang Weber | Germany | |
| Future Perspectives of Theranostics in USA | Richard Wahl | USA | |
| Lunch (12:00-13:00) | |||
| Poster and Exhibition (13:00-14:00) | |||
| Keynote 2 (14:00-14:30) |
Practical Applications and Future Prospects of Radiotheranostics | Michael Hofman | Australia |
| Chair: Richard Wahl | |||
| Scientific Session 2 (14:30-15:30) |
Theranostics of Prostate Cancer |
|
|
| Chairs: | Unmet Clinical Needs in Advanced Prostate Cancer | Cheol Kwak | Korea |
| Gi Jeong Cheon | Targeting Non-cullin Neddylation to Combat Neoplastic and Metabolic Diseases | Yang-sook Chun | Korea |
| Hee-Seung Bom | Simplest Glu-Urea-Lys (EUK) for PSMA | Yun-Sang Lee | Korea |
| Theranostic Agents for Targeting PSMA: Development of 18F and Alpha Emitters | Dae Yoon Chi | Korea | |
| Reports 1 (15:30-16:00) |
Current Status of Theranostics in Asia | ||
| Chair: | Theranostics in Korea | Keon Wook Kang | Korea |
| Keon Wook Kang | Theranostics in Japan | Seigo Kinuya | Japan |
| Theranostics in China | Feng Wang | China | |
| Coffee Break (16:00-16:30) and Exhibition | |||
| Scientific Session 3-1 (16:30-18:00) |
Next Generation Theranostics (from Chemists' Point of View) - Novel Targets and Probes | ||
| Chairs: | Instant Kit-type Labelling Chemistry for 68Ga, 44Sc, 177Lu. | Frank Rösch | Germany |
| Frank Rösch | Image Guided Therapy: Development of Oncologic and Non-oncologic Agents | Henry VanBrocklin | USA |
| Henry VanBrocklin | Potential Use of Hypoxia and Thymidine Phosphorylase Imaging Probes for Theranostics | Yuji Kuge | Japan |
| Imaging of the Third Gasotransmitter | Jae Min Jeong | Korea | |
| Keynote 3 (08:00-08:30) | Radiohybrids: A Groundbreaking New Theranostics Tracer Concept | Hans-Jürgen Wester | Germany |
| Chair: Dae Yoon Chi | |||
| Scientific Session 3-2 (08:30-09:30) |
Next Generation Theranostics (from Chemists' Point of View) - Alpha Emitters | ||
| Chairs: | Precision Treatment: Production of Alpha Emitters for Targeted Therapies to Kill Cancer Cells | Cathy Cutler | USA |
| Baljinder Singh | 203Pb/212Pb Peptide Receptor Targeted Theranostics for Cancer | Michael K. Schultz | USA |
| Cathy Cutler | The Heidelberg Series of Glu-ureido based PSMA Tracers: Adaption of Chemical Structure to Clinical Indication | Klaus Kopka | Germany |
| Reports 2 (09:30-10:30) |
Global Practical Progress | ||
| Chairs: | Implementation of Novel Theranostics in Africa | Mike Sathekge | South Africa |
| Patricia Bernal Trujillo | Struggles of Theranostics in Latin America | Patricia Bernal Trujillo | Colombia |
| Mike Sathekge | Theranostics Efforts between Europe and Asia | Fani Bozkurt | Turkey |
| Optimization of Novel Radionuclide Therapies in India | Partha Choudhury | India | |
| PSMA PET in Initial Management of Prostate Cancer; Experience from the Arab World | Akram Al-Ibraheem | Jordan | |
| Coffee Break (10:30-11:00) and Exhibition | |||
| Keynote 4 (11:00-11:30) | Intelligence-based vs Evidence-based: How AI will Shape the Future of Theranostics to Achieve True Personalized Medicine | Anthony Chang | USA |
| Chair: Richard Baum | |||
| Scientific Session 4 (11:30-12:30) |
Next Generation Theranostics (from Physicists' Point of View) | ||
| Chairs: | Prospective Dosimetry Options for Alpha-emitter Targeted Therapy | Mark Konijnenberg | The Netherlands |
| Mark Konijnenberg | Voxel-based dosimetry of 177Lu-IONPs-folate using SPECT/CT imaging of mice | Arun Gupta | Nepal |
| Jae Sung Lee | New Approaches to Fast Voxel-based Dosimetry | Jae Sung Lee | Korea |
| ICRP Perspectives for Individualized Radionuclide Therapy | Makoto Hosono | Japan | |
| TEIN Luncheon Seminar (12:30-14:00) |
TEIN Luncheon Seminar | TEIN In his/her own country | |
| Chairs: | On-Site Speaker: Lingeswaran Kasilingam (Malaysia), Hendra Budiawan (Indonesia), | ||
| Dong Soo Lee | Pham Cam Phuong (Vietnam), Shamim Momtaz Ferdousi Begum (Bangladesh), | ||
| Teik-Hin Tan (in Kuala Lumpur) | Noboru Oriuchi (Japan), Ting Kun Au Yong (Hong Kong), | ||
| David Ng (Singapore), Hong Zhang (China), | |||
| Humayun Bashir (Pakistan), Patricia Bautista (Philippines) | |||
| Participants who Connect via TEIN Video Conferencing from their Home Country: | |||
| Sadia Sultana (National Institute of Nuclear Medicine & Allied Science, Bangladesh), | |||
| Karisma Perdani (Hasan Sadikin Hospital Bandung, Indonesia), | |||
| Wong Tect Huat (Malaysia), Jefferson Pagsisihan (Philippines), | |||
| Apichaya Cliamon, Tawatchai Chaiwatanarat (Thailand), | |||
| Nguyen Thuan Loi (Vietnam) | |||
| Poster and Exihibition (14:00-14:30) | |||
| Keynote 5 (14:30-15:00) | Personalized Cancer Therapy: From Innovation to Implementation using Theranostics and Precision Oncology | Richard Baum | Germany |
| Chair: Hans-Jürgen Wester | |||
| Scientific Session 5-1 (15:00-16:00) |
Next Generation Theranostics (from Convergents' Point of View) | ||
| Chairs: | Antibody Theranostics | Anna Wu | USA |
| Jung-Joon Min | In Vitro to in Vivo Companion Diagnostics | Young Kee Shin | Korea |
| Anna Wu | Bacteria-based Radio-theranostics | Jung-Joon Min | Korea |
| Gastrin-Releasing Peptide Receptors for Theranostics in Prostate Cancer | Andrei Iagaru | USA | |
| Coffee Break (16:00-16:30) and Exhibition | |||
| Scientific Session 5-2 (16:30-17:50) |
Next Generation Theranostics (from Physicians' Point of View) | ||
| Chairs: | Theranostics in Combination with Local Therapies | Michael Kreissl | Germany |
| Michael Kreissel | PSMA Targeting Alpha Therapies | Wolfgang Weber | Germany |
| Steve Yoon-Ho Cho | Immune Cell-based Theranostics | Il Minn | USA |
| Imaging Criteria for Assessing Response to Theranostics – Challenges and Opportunities | Steve Yoon-Ho Cho | USA | |
| Reports 3 (17:50-18:20) |
Standpoints of Patient Advocates | ||
| Chairs: | USA Experiences | Josh Mailman | USA |
| Keon Wook Kang | Korean Experiences | Song-hoon Ham | Korea |
| Josh Mailman | Japanese Experiences | Yoshiyuki Majima | Japan |
| Scientific Session 5-3 (08:00-09:20) |
Next Generation Theranostics (from Innovators' Point of View) | ||
| Chairs: | Nanomedicine: 11 Years of European Efforts of the European Foundation for Clinical Nanomedicine | Beat Loeffler | Switzerland |
| Dong Soo Lee | Introduction to Radionanomedicine | Dong Soo Lee | Korea |
| Beat Loeffler | Radiolabeled Nanomaterials | Weibo Cai | USA |
| Ceria-based Nanoparticle Therapy against ROS-mediated Injury | Seung-Hoon Lee | Korea | |
| Theranostics of Exosomes on Alzheimer’s disease | Ren-Shyan Liu | Taiwan | |
| Coffee Break (09:20-09:40) and Exhibition | |||
| Read with the Experts (09:40-10:40) |
Selected Poster Presentation | Expert/Speaker | |
| Chairs: | In the assessment of biodistribution and metabolism for α-methylation on 18F-labeled tryptophan derivative. | Ho Young Kim | Korea |
| Richard Baum | Enhancing SSTR2-targeted alpha-particle therapy for neuroendocrine tumors with everolimus and histone deacetylase inhibitors | Dongyoul Lee | USA |
| Byeong-Cheol Ahn | Targeted Alpha-Particle Therapeutics Adaptation of Clinical Routinely produced 225Ac-labeled Radiopharmaceuticals | Dirk Müller | Germany |
| First-in-human study of a novel somatostatin receptor antagonist 68Ga-NODAGA-LM3 for molecular imaging of paraganglioma patients | Jingjing Zhang | Germany | |
| Treatment of Predominantly Lymph Node Metastatic Prostate Cancer with 177Lu-PSMA Radioligand Therapy | Danielle Meyrick | Australia | |
| Chemokine receptor CXCR4-targeted PET/CT with 68Ga-pentixafor shows superiority to 18F-FDG in evaluation of multiple myeloma | Yaping Luo | China | |
| Share the Experiences (10:40-11:40) |
Open Discussion: How to Implement Novel Theranostics Overcoming Difficulties of Starting Institutions | Panels | |
| Chairs: | Panels from the Starting Institutions | Wen-Sheng Huang | Taiwan |
| Gi Jeong Cheon | Lingeswaran Kasilingam | Malaysia | |
| Mike Sathekge | Hendra Budiawan | Indonesia | |
| Pham Cam Phuong | Vietnam | ||
| Shamim Momtaz Ferdousi Begum | Bangladesh | ||
| Patricia Bautista | Philippines | ||
| Humayun Bashir | Pakistan | ||
| Keynote 6 (11:40-12:10) | Brain Theranostics | Dong Soo Lee | Korea |
| Chair: Edmund Kim | |||
| Closing Remarks (12:10-13:00) |
Hand-over Ceremony to the Next Congress Chairpersons | Dong Soo Lee/Jae Min Jeong to Horacio Amaral / Vasko Kramer | |
